Briggs W. Morrison
2017
In 2017, Briggs W. Morrison earned a total compensation of $1.7M as Chief Executive Officer at Syndax Pharmaceuticals, a 92% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $204,500 |
|---|---|
| Option Awards | $920,012 |
| Salary | $549,585 |
| Other | $3,000 |
| Total | $1,677,097 |
Morrison received $920K in option awards, accounting for 55% of the total pay in 2017.
Morrison also received $204.5K in non-equity incentive plan, $549.6K in salary and $3K in other compensation.
Rankings
In 2017, Briggs W. Morrison's compensation ranked 6,403rd out of 14,666 executives tracked by ExecPay. In other words, Morrison earned more than 56.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,403 out of 14,666 | 56th |
Division Manufacturing | 2,357 out of 5,768 | 59th |
Major group Chemicals And Allied Products | 749 out of 2,074 | 64th |
Industry group Drugs | 578 out of 1,730 | 67th |
Industry Pharmaceutical Preparations | 457 out of 1,329 | 66th |
Source: SEC filing on April 10, 2018.
Morrison's colleagues
We found two more compensation records of executives who worked with Briggs W. Morrison at Syndax Pharmaceuticals in 2017.
News
Syndax Pharmaceuticals CEO Briggs Morrison's 2021 pay jumps 80% to $3.9M
March 29, 2022
Syndax Pharmaceuticals CFO Daphne Karydas receives $3.1M in 2020
April 1, 2021
Syndax Pharmaceuticals COO Michael Metzger's 2019 pay jumps 77% to $2.7M
April 29, 2020
Syndax Pharmaceuticals CEO Briggs Morrison's 2018 pay jumps 24% to $2.1M
April 30, 2019